Fortress Biotech, Inc. (FBIO)
2.70
-0.04
(-1.28%)
USD |
NASDAQ |
Sep 01, 14:54
Fortress Biotech Total Long Term Debt (Quarterly) : 46.07M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 46.07M |
| March 31, 2026 | 48.91M |
| December 31, 2025 | 65.09M |
| September 30, 2025 | 66.16M |
| June 30, 2025 | 67.08M |
| March 31, 2025 | 72.08M |
| December 31, 2024 | 73.34M |
| September 30, 2024 | 69.02M |
| June 30, 2024 | 85.94M |
| March 31, 2024 | 82.04M |
| December 31, 2023 | 82.14M |
| September 30, 2023 | 67.74M |
| June 30, 2023 | 78.60M |
| March 31, 2023 | 120.08M |
| December 31, 2022 | 124.90M |
| September 30, 2022 | 123.14M |
| June 30, 2022 | 116.88M |
| March 31, 2022 | 116.59M |
| December 31, 2021 | 72.87M |
| September 30, 2021 | 90.14M |
| June 30, 2021 | 96.97M |
| March 31, 2021 | 96.20M |
| December 31, 2020 | 87.23M |
| September 30, 2020 | 74.25M |
| June 30, 2020 | 109.23M |
| Date | Value |
|---|---|
| March 31, 2020 | 109.04M |
| December 31, 2019 | 108.37M |
| September 30, 2019 | 108.18M |
| June 30, 2019 | 108.21M |
| March 31, 2019 | 107.87M |
| September 30, 2018 | 84.26M |
| June 30, 2018 | 84.03M |
| March 31, 2018 | 86.10M |
| December 31, 2017 | 66.51M |
| September 30, 2017 | 63.62M |
| June 30, 2017 | 46.95M |
| March 31, 2017 | 33.03M |
| December 31, 2016 | 28.22M |
| September 30, 2016 | 27.40M |
| June 30, 2016 | 21.80M |
| March 31, 2016 | 20.75M |
| December 31, 2015 | 23.17M |
| September 30, 2015 | 23.29M |
| June 30, 2015 | 23.23M |
| March 31, 2015 | 24.01M |
| December 31, 2014 | 14.01M |
| September 30, 2014 | 14.01M |
| June 30, 2014 | 14.01M |
| March 31, 2014 | 14.01M |
| December 31, 2013 | 13.62M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | 5.103M |
| Ironwood Pharmaceuticals, Inc. | 393.58M |
| Kura Oncology, Inc. | 23.16M |
| Spero Therapeutics, Inc. | 0.043M |
| Cue Biopharma, Inc. | 7.179M |